Aditya Birla Capital
ABC Home
Loans
Investments
Insurance
Payments
Download ABCD

Experience finance made simple on the new ABCD app!

Scan to Download the App

Playstore Appstore
1800-270-7000

Aditya Birla Sun Life AMC Limited

Aditya Birla Sun Life AMC Limited

    Our Menu
    Invest with Us
    Metaverse

    Aditya Birla Sun Life AMC Limited

    • Home
    • Blog
    • Indian Pharma and Healthcare Industry: Making of a Behemoth
    Add to Wishlist

    Indian Pharma and Healthcare Industry: Making of a Behemoth

    Jul 05, 2019
    2 mins | Views 11983

    Indian Pharmaceutical Industry has The Twin Engines of Growth

    Domestic Growth: To touch US $57 billion in 2030 growing @ 10% -12%1

    Export Surge: To touch US $44 billion in 2030 growing @ 8% - 10%2

    Factors fuelling the engines:


      Domestic Growth Drivers

    • Rising in Life Expectancy3

    • US $200 bn is expected to be spent on Medical Infrastructure by 2024 4

    • Increasing Health Insurance Penetration

    • Rising Private & Government Healthcare Spending.

    • Introduction of “Ayushman Bharat”, the largest Healthcare scheme in the world5

      Export Growth Drivers

    • Pharmergence - Emerging countries accounts for 24% of Global Pharma Market6

    • India - largest producer of the Generic Medicines Globally

    • Over 80% of world’s Antiretroviral (AIDS) Drugs supplied by India7

    • Approx. 40% lower cost of production in India vis-a-vis China and Eastern Europe8

    • India on its way to become the World’s one-stop-shop for Contract research and manufacturing services (CRAMS)9

    Changing facet of Healthcare in India

    • Emergence of Private Hospitals as Mass Caregivers.10

    • Rapid expansion & consolidation of Diagnostics Market.

    • Rising customization & at-home provision of Diagnostics & Disease Management

    • Emergence of Health-tech Start-ups

    • Rising trend of Wellness, Good living & Grooming increasing the demand for Therapeutic, Cosmeceutical & Derma products

    Two-pronged transformation of Healthcare landscape by integrating the Pharma ‘Manufacturing’ and ‘Healthcare Services’ in India.

    Welcome to the New Dawn of Pharma & Healthcare Industry.

    Aditya Birla Sun Life Pharma & Healthcare Fund - An open-ended equity scheme investing in Pharma and Healthcare Services Sector Click here to know more

    Sources:

    https://www.ibef.org/industry/indian-pharmaceuticals-industry-analysis-presentation

    2 https://www.ibef.org/industry/indian-pharmaceuticals-industry-analysis-presentation

    3 https://www.worldlifeexpectancy.com/india-life-expectancy

    4 https://www.investindia.gov.in/sector/healthcare

    5 https://www.ibef.org/industry/healthcare-india/infographic

    6 https://www.marketwatch.com/press-release/healthcare-global-market-report-2018-2018-09-17

    7 https://www.ibef.org/ind5ustry/pharmaceutical-india.aspx

    8 http://ficci.in/spdocument/22944/india-pharma-2018-ficci.pdf

    9 http://ficci.in/spdocument/22944/india-pharma-2018-ficci.pdf

    10 https://www.ibef.org/download/Healthcare-January-2017.pdf

    Mutual Fund investments are subject to market risks, read all scheme related documents carefully.

    Add to Wishlist
    Rate this
    Rate this Article
    Leave a comment
    Comment required
    Name Required
    Email ID required
    SUBMIT COMMENT
    Load More

    blog_OurExpertOur Experts

    ToolAndCalculatorTools and Calculator

    eAssistance

    Give us a call on

    1800 270 7000 within India

    Get a call back

    RSSRSS News Feed

    blog_archives.pngArchives

    Please Select Month
    Please Select Year
    Close
    Hover to Zoom